new targeted agents in breast cancer palbociclib & beyond
Published 8 years ago • 1.6K plays • Length 27:44Download video MP4
Download video MP3
Similar videos
-
6:29
study of palbociclib after cdk & endocrine therapy in er /her2- metastatic breast cancer
-
3:20
novel targeted drug palbociclib slows progression of hormone receptor-positive breast cancer
-
13:22
palbociclib and breast cancer
-
3:34
novel targeted drug palbociclib slows progression of hormone receptor-positive breast cancer
-
5:43
cdk 4/6 inhibitor, palbociclib, for the treatment of metastatic breast cancer
-
39:21
bcfnz webinar: palbociclib (ibrance) for advanced or metastatic hr breast cancer - nz update
-
0:55
fulvestrant plus palbociclib in breast cancer
-
2:02
palbociclib combined with fulvestrant in relapsed metastatic hr /her2- breast cancer
-
12:43
palbociclib in breast cancer
-
3:00
new treatment option for women with advanced breast cancer | ucla vital signs
-
29:09
interactive case: choosing and using cdk4/6 inhibitors in breast cancer - first-line therapy
-
4:37
case 2: cdk4/6 inhibitors in er breast cancer
-
1:43
composite biomarkers predictive of palbociclib endocrine treatment benefit in early breast cancer
-
2:11
the use of frontline cdk4/6 inhibitors endocrine therapy in metastatic breast cancer
-
53:49
ask the expert: metastatic breast cancer with tufia c. haddad, md
-
4:35
hr breast cancer: differences between cdk4/6 inhibitors
-
2:06
unmet needs and cdk4/6 inhibitors in hr /her2- early breast cancer
-
26:08
metastatic hormone positive breast cancer | 2023 ku breast cancer year in review conference
-
30:44
what's new for the patient with er /her2- mbc progressing on cdk 4/6 inhibitor therapy? expert pe...